NCT05238103Completed
Impact of a Corrie Cardiac Rehabilitation Program
Impact of a Mobile Technology Enabled Corrie Cardiac Rehabilitation Program on Functional Status and Cardiovascular Outcomes (mTECH-Rehab): A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 5 Dec 2025
Brief summary (registry, in English)
In this randomized clinical trial, the researchers are investigating whether a multi-component virtual/hybrid cardiac rehabilitation program will improve functional status, cholesterol level, overall cardiovascular health, individual risk factors, quality of life and mental health for patients who have recently been diagnosed with myocardial infarction, received a coronary stent, underwent heart surgery or catheter-based valve replacement, as compared to traditional, center-based cardiac rehabilitation.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 259 (actual)
- First submitted
- 3 Feb 2022
- Start date
- 3 Apr 2023
- Primary completion date
- 14 Oct 2024
- Lead sponsor
- Johns Hopkins University
- Diseases
- Coronary artery disease
- NCT number
- NCT05238103
What you commit to
- Study type: Interventional
- Participants enrolled: 259
- From 3 Apr 2023 to the primary completion date, 14 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Symptomatic severe aortic stenosis or other severe valvular disease
- Severe resting arterial hypertension (Systolic blood pressure \>200 mmHg or diastolic BP \>110mmHg) at baseline assessment
- Mental impairment leading to inability to cooperate with study procedures
- Atrial fibrillation with uncontrolled ventricular rate (Heart rate \>110 at rest) at baseline assessment
- History of cardiac arrest or sudden death
- Myocardial infarction or cardiac surgery complications with cardiogenic shock and/or congestive heart failure and/or signs/symptoms of post-procedure ischemia
- History of Clinically significant depression
- Visual or hearing impairment which precludes the use of the intervention
- Presence of cardiac defibrillator
- History of one or more episodes of falls in the last year
Lab values
- Left ventricular ejection fraction \<40%
Other
- Non-English speaking
- Physical disability that would preclude safe and adequate exercise performance
- Hypertrophic obstructive cardiomyopathy with peak resting left ventricular outflow gradient of \>25 mmHg
- Known aortic dissection
- Untreated high degree atrioventricular block
- Incomplete revascularization procedure
- Pregnancy
- If patients are deemed clinically unstable and unable to participate at the time of initial screening, the research team member may return at a later date to determine whether this status has changed.
Who the study is looking for
- 18 years or older
- Individuals admitted to the hospital for the following conditions or interventions during the index admission: Acute myocardial infarction (STEMI or NSTEMI type 1), Coronary artery bypass grafting (CABG), and Coronary artery angioplasty/stenting (PCI), Heart valve surgery, catheter-based aortic valve replacement (TAVR).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins University Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.